Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
China’s Jiangsu Hansoh Pharmaceutical plans up to $3 Billion Hong Kong IPO
Wednesday, January 06, 2016A large Chinese pharmaceutical company is planning to raise up to billion in a Hong Kong initial public offering later this year tapping demand to invest in Chinas growing healthcare market according to people familiar with the matter Jiangsu Hanso...
The Carlyle Group and Bourne Partners form Phoenix Therapeutics to build global pharma company
Wednesday, January 06, 2016Global alternative asset manager The Carlyle Group announced that it has formed a joint venture with Bourne Partners a healthcarefocused investor operator and investment banking firm to build a global pharmaceutical platform This new venture known as...
Takeda Pharmaceutical acquires U.S. Biologics manufacturing facility
Wednesday, January 06, 2016Takeda Pharmaceutical Company Limited today announced the acquisition of a biologics manufacturing facility located in Brooklyn Park Minnesota US from Baxalta US Inc BXLT Takeda intends to use the facility primarily for the manufacture of Entyvio ved...
Drug approvals at 19-year high belie industry challenges
Tuesday, January 05, 2016was a good year for innovation in medicine with the US Food and Drug Administration approving novel drugs four more than in and the most since the alltime record of set in Across the Atlantic the European Medicines Agency recommended new produ...
Drugmaker Baxalta in deal to expand immuno-oncology business
Tuesday, January 05, 2016Drugmaker Baxalta Inc has signed a deal with privately held Symphogen under which the companies will develop immunooncology drugs to treat rare cancers The agreement holds a total potential value up to billion euros billion in option fees and mile...
Teva, Active Biotech halt higher doses of oral MS drug in trials
Tuesday, January 05, 2016Teva Pharmaceutical Industries and Active Biotech will discontinue higher doses of their oral drug in development for multiple sclerosis in two trials citing the occurrence of nonfatal cardiovascular events in eight patients Both trials of laquinimo...
Hikma Pharmaceuticals receives FDA approval for Neostigmine Methylsulfate Injection
Tuesday, January 05, 2016Hikma Pharmaceuticals PLC the fast growing multinational pharmaceutical group announces that its Abbreviated New Drug Application ANDA for Neostigmine Methylsulfate Injection USP mg mL and mg mL multipledose vials has been approved by the US Food a...
Underwriters buy additional $658 mln in Teva Pharm shares
Monday, January 04, 2016The underwriters for Teva Pharmaceutical Industries share offering last month have exercised their overallotment option to purchase additional shares worth million That brings the total proceeds of the share offering to billion Israelbased Teva sa...
AstraZeneca needs to set itself free
Monday, January 04, 2016AstraZeneca may need more freedom of movement The UK pharmaceuticals company has been bolstering profits with a series of externalization deals designed to keep its earnings per share above That is one of the targets baked into management pay plans...
Dublin-based Shire in advanced talks to acquire Baxalta for $32bn
Monday, January 04, 2016Shire the pharmaceutical company based in Dublin is in advanced talks to acquire Baxalta for about billion billion in cash and stock excluding debt sources have said The two drugmakers may announce a deal this week The price being discussed is t...
